Kongsberg Gruppen ASA (OSL:KOG)

CTI BioPharma Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	259,657	225,161	81,866	73,409	50,383	31,681
Market Cap Growth	124.89%	175.04%	11.52%	45.70%	59.04%	27.56%
Enterprise Value	251,220	223,331	86,479	75,793	48,833	29,222
Last Close Price	295.55	254.50	91.16	79.33	52.04	30.88
PE Ratio	38.74	43.93	22.05	26.47	23.34	10.96
Forward PE	33.38	37.31	21.34	24.69	20.89	20.45
PS Ratio	4.89	4.61	2.02	2.31	1.84	1.24
PB Ratio	13.67	11.69	4.97	5.34	3.70	2.38
P/TBV Ratio	21.65	15.94	7.22	8.14	5.30	3.50
P/FCF Ratio	23.12	18.75	21.18	163.13	11.44	14.56
P/OCF Ratio	20.03	16.38	14.05	66.37	10.14	11.52
PEG Ratio	1.34	1.44	1.06	0.90	0.86	0.70
EV/Sales Ratio	4.73	4.57	2.13	2.38	1.78	1.14
EV/EBITDA Ratio	28.06	30.78	16.30	19.02	13.72	10.65
EV/EBIT Ratio	32.84	34.21	18.63	22.75	16.99	14.47
EV/FCF Ratio	22.37	18.60	22.38	168.43	11.08	13.43
Debt / Equity Ratio	0.28	0.24	0.30	0.32	0.32	0.42
Debt / EBITDA Ratio	0.62	0.61	0.84	0.99	1.09	1.76
Debt / FCF Ratio	0.47	0.39	1.26	9.77	0.98	2.56
Asset Turnover	0.83	0.80	0.84	0.77	0.70	0.66
Inventory Turnover	2.96	2.51	2.49	2.29	2.27	2.19
Quick Ratio	0.86	0.91	0.85	0.82	1.03	0.98
Current Ratio	1.06	1.13	1.14	1.12	1.29	1.24
Return on Equity (ROE)	38.20%	28.79%	24.60%	20.54%	17.01%	11.34%
Return on Assets (ROA)	7.05%	6.65%	6.02%	5.04%	4.57%	3.23%
Return on Capital (ROIC)	19.95%	18.01%	14.69%	11.54%	9.76%	6.65%
Return on Capital Employed (ROCE)	29.50%	25.40%	20.60%	17.40%	14.30%	10.30%
Earnings Yield	2.58%	2.28%	4.53%	3.78%	4.29%	9.13%
FCF Yield	4.32%	5.33%	4.72%	0.61%	8.74%	6.87%
Dividend Yield	1.49%	0.79%	1.54%	0.91%	1.27%	1.94%
Payout Ratio	45.22%	48.05%	17.19%	98.67%	66.70%	15.57%
Buyback Yield / Dilution	-0.05%	0.10%	0.73%	0.92%	0.43%	0.09%
Total Shareholder Return	1.42%	0.88%	2.26%	1.83%	1.70%	2.04%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.